TFS HealthScience snaps up niche CRO Appletree in ophthalmology expansion
25 Jan 2023
Acquisition
Preview
Source: FierceBiotech
Switzerland-based Appletree has a presence in 11 European countries.
Sweden’s TFS HealthScience snapped up niche CRO Appletree CI Group for an undisclosed price in a move to expand into the growing ophthalmology arena.
TFS, which is based in Lund, Sweden with operations throughout Europe and North America said in a Jan. 23 release that the acquisition will also extend its geographic reach as well as provide additional expertise in dermatology, medical devices and pediatric studies.
Switzerland-based Appletree, which was founded in 2013 in the wake of the merger of Clinical Investigations and Appletree AG, has a presence in 11 European countries and also has expertise in regulatory affairs.
"The strategic acquisition of Appletree will complement TFS HealthScience’s mission to be a market leader in ophthalmology research,” TFS CEO Bassem Saleh said in the release. “In a targeted business shift toward ophthalmology expertise, the company launched its elite site network initiative and site liaison services, which will shift the industry’s approach to ophthalmology clinical trial delivery.”
TFS cited a recent study published in The Journal of American Medicine that estimates research funding for ophthalmology grew 203% from 2014 to 2020. The study also forecast the global ophthalmology drug market to hit $60.3 billion by 2028, an increase of 6.4% from 2021 figures.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.